Carlo Baldassarre Federici
Government, Health and Not for Profit
Biography
Carlo Federici is a Researcher of Health Economics and Health Technology Assessment (HTA) at the Center for Research on Health and Social Care Management (CERGAS) of SDA Bocconi School of Management.
At SDA Bocconi Carlo teaches the Advanced Decision Modelling course at the Master of International Healthcare Management, Economics and Policy (MIHMEP) as well as several courses on HTA and economic evaluations of healthcare technologies. He conducted numerous research, training and consulting projects with Medtronic, Janssen, ABBOTT, Chiesi Farmaceutica, Assobiomedica, and many others. He contributed to several European research projects such as the H2020 projects MedtecHTA and COMED addressing the assessment of medical devices from different perspectives. In the past years, Carlo has also conducted several research activities with the Italian Ministry of Health on both reimbursement and regulatory aspects of medical technologies.
His research activities focus on the area of HTA and Health Policy Evaluation. His current research addresses both methodological aspects as well as applied case studies on decision analytical models to estimate cost-effectiveness of innovative health technologies as compared to other policy options. Other recent research areas include the identification of different dimensions of value when assessing health interventions, such as for example the real option value and insurance value of health technologies; the impact of technologies characteristics on organizational impact and operations management; or the study of performance-based risk sharing agreements between payers and technology developers (e.g., coverage with evidence development, payment by results etc.)
He is the author of numerous articles on the subject. His work has been published in Journal of Value in Health, PlosOne, Pharmacoeconomics, Health Policy among others. Carlo serves as a topic editor in the pharmaeconomics and outcome research area for the Journal Clinical Therapeutics. He is a member of the Italian Association of Health Economics (AIES) and the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).
Carlo earned his MSc in Health Economics from the University of York and his Ph.D. at the University of Warwick.
Teaching domains
Markov Models
Economic Evaluations of Drugs
Meta-Analysis
Survival Analysis
Statistics for Clinical Studies
Latest publications
I dati amministrativi per la governance dei tempi di attesa delle prestazioni ambulatoriali: l’esperienza dell’Azienda Sanitaria dell’Alto Adige
Mecosan, 2023, no. 123, pp.53-75
Esiti di salute e performance del Servizio Sanitario Nazionale in Rapporto OASI 2022
CERGAS (Eds),Egea, chap. 7, pp.285-346, 2022
Use of Resource Modeling to Quantify the Organizational Impact of Subcutaneous Formulations for the Treatment of Oncologic Patients: The Case of Daratumumab in Multiple Myeloma
Clinical Therapeutics, 2022, vol.44, no. 11, pp.1480-1493
An approach to quantify parameter uncertainty in early assessment of novel health technologies
Health Economics, 2022, vol.31, no. S1, pp.116-134
Coverage with evidence development for medical devices in Europe: Can practice meet theory?
Health Economics, 2022, vol.31, no. S1, pp.179-194
Exploring the misalignment on the value of further research between payers and manufacturers. A case study on a novel total artificial heart
Health Economics, 2022, vol.31, no. S1, pp.98-115
